Neogen Chemicals Limited (NSE:NEOGEN)
India · Delayed Price · Currency is INR 1,858.10
+80.70 (4.54%)
May 29, 2026, 3:30 PM IST
Neogen Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 8,620 | 7,776 | 6,907 | 6,862 | 4,873 | |
Revenue Growth (YoY) | 10.85% | 12.58% | 0.65% | 40.83% | 44.84% |
Cost of Revenue | 4,665 | 4,289 | 3,876 | 3,940 | 2,750 |
Gross Profit | 3,955 | 3,486 | 3,031 | 2,922 | 2,123 |
Selling, General & Admin | 900.8 | 685.9 | 659.9 | 499.6 | 334.1 |
Other Operating Expenses | 1,681 | 1,439 | 1,272 | 1,307 | 924.4 |
Operating Expenses | 2,857 | 2,401 | 2,159 | 1,967 | 1,374 |
Operating Income | 1,098 | 1,085 | 871.8 | 954.2 | 749 |
Interest Expense | -751.1 | -378.6 | -377.8 | -237 | -178 |
Interest & Investment Income | - | 15.7 | 74.1 | 38.3 | 6 |
Earnings From Equity Investments | 2.8 | 2 | 1.8 | 1 | 1.8 |
Other Non Operating Income (Expenses) | 61.4 | -82 | -42.2 | -46.2 | -12 |
EBT Excluding Unusual Items | 410.8 | 642.4 | 527.7 | 710.3 | 566.8 |
Gain (Loss) on Sale of Investments | - | - | - | - | 3.9 |
Other Unusual Items | - | -140.8 | - | - | - |
Pretax Income | 410.8 | 501.6 | 527.7 | 710.3 | 570.7 |
Income Tax Expense | 123.3 | 153.3 | 171.2 | 210.6 | 124.4 |
Net Income | 287.5 | 348.3 | 356.5 | 499.7 | 446.3 |
Net Income to Common | 287.5 | 348.3 | 356.5 | 499.7 | 446.3 |
Net Income Growth | -17.46% | -2.30% | -28.66% | 11.96% | 42.45% |
Shares Outstanding (Basic) | 26 | 26 | 26 | 25 | 25 |
Shares Outstanding (Diluted) | 26 | 26 | 26 | 25 | 25 |
Shares Change (YoY) | -0.02% | 3.29% | 2.41% | - | 6.88% |
EPS (Basic) | 10.90 | 13.20 | 13.96 | 20.04 | 17.90 |
EPS (Diluted) | 10.90 | 13.20 | 13.96 | 20.03 | 17.90 |
EPS Growth | -17.42% | -5.43% | -30.31% | 11.93% | 33.28% |
Free Cash Flow | -7,872 | -1,217 | -3,319 | -1,328 | -1,689 |
Free Cash Flow Per Share | -298.45 | -46.13 | -129.96 | -53.27 | -67.71 |
Dividend Per Share | 1.000 | 1.000 | 2.000 | 3.000 | 2.750 |
Dividend Growth | - | -50.00% | -33.33% | 9.09% | 22.22% |
Gross Margin | 45.88% | 44.84% | 43.88% | 42.58% | 43.57% |
Operating Margin | 12.73% | 13.96% | 12.62% | 13.91% | 15.37% |
Profit Margin | 3.33% | 4.48% | 5.16% | 7.28% | 9.16% |
Free Cash Flow Margin | -91.33% | -15.65% | -48.06% | -19.36% | -34.66% |
EBITDA | 1,373 | 1,293 | 1,054 | 1,094 | 848.6 |
EBITDA Margin | 15.93% | 16.63% | 15.26% | 15.95% | 17.42% |
D&A For EBITDA | 275.2 | 208.1 | 181.9 | 140.1 | 99.6 |
EBIT | 1,098 | 1,085 | 871.8 | 954.2 | 749 |
EBIT Margin | 12.73% | 13.96% | 12.62% | 13.91% | 15.37% |
Effective Tax Rate | 30.01% | 30.56% | 32.44% | 29.65% | 21.80% |
Revenue as Reported | 8,681 | 7,816 | 6,981 | 6,906 | 4,883 |